Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
James Ferrara
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Living Beings
Anatomy
Chemicals & Drugs
Physiology
Sign-in to see full Profile
Network (preview)
37
Cooke, Kenneth
28
Reddy, Pavan
25
Teshima, Takanori
20
Burakoff, Steven
20
Liu, Chen
19
Levine, John
17
Hill, GR
14
Yanik, Gregory
13
Mauch, Peter
13
Antin, Joseph
12
Clouthier, Shawn
12
Hutchinson, Raymond
10
Lowler, Kathleen
10
Pan, L
10
Crawford, James
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of James Ferrara (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Paczesny Sophie; Choi Sung W; Ferrara James L M
Acute graft-versus-host disease: new treatment strategies.
Current opinion in hematology 2009;16(6):427-36.
-
2009: Knobler Robert; Barr Mark L; Couriel Daniel R; Ferrara James L M; French Lars E; Jaksch Peter; Reinisch Walter; Rook Alain H; Schwarz Thomas; Greinix Hildegard
Extracorporeal photopheresis: past, present, and future.
Journal of the American Academy of Dermatology 2009;61(4):652-65.
-
2009: Ferrara James L M; Levine John E; Reddy Pavan; Holler Ernst
Graft-versus-host disease.
Lancet 2009;373(9674):1550-61.
-
2009: Paczesny Sophie; Levine John E; Braun Thomas M; Ferrara James L M
Plasma biomarkers in graft-versus-host disease: a new era?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1 Suppl):33-8.
-
2009: Paczesny Sophie; Krijanovski Oleg I; Braun Thomas M; Choi Sung W; Clouthier Shawn G; Kuick Rork; Misek David E; Cooke Kenneth R; Kitko Carrie L; Weyand Angela; Bickley Daniel; Jones Dawn; Whitfield Joel; Reddy Pavan; Levine John E; Hanash Samir M; Ferrara James L M
A biomarker panel for acute graft-versus-host disease.
Blood 2009;113(2):273-8.
-
2008: Ferrara James L M
Advances in the clinical management of GVHD.
Best practice & research. Clinical haematology 2008;21(4):677-82.
-
2008: Yanik Gregory A; Ho Vincent T; Levine John E; White Eric S; Braun Thomas; Antin Joseph H; Whitfield Joel; Custer Joseph; Jones Dawn; Ferrara James L M; Cooke Kenneth R
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.
Blood 2008;112(8):3073-81.
-
2008: Levine John E; Blazar Bruce R; DeFor Todd; Ferrara James L M; Weisdorf Daniel J
Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(9):1017-21.
-
2008: Choi Sung W; Kitko Carrie L; Braun Thomas; Paczesny Sophie; Yanik Gregory; Mineishi Shin; Krijanovski Oleg; Jones Dawn; Whitfield Joel; Cooke Kenneth; Hutchinson Raymond J; Ferrara James L M; Levine John E
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.
Blood 2008;112(4):1539-42.
-
2008: Gatza Erin; Rogers Clare E; Clouthier Shawn G; Lowler Kathleen P; Tawara Isao; Liu Chen; Reddy Pavan; Ferrara James L M
Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells.
Blood 2008;112(4):1515-21.
-
2008: Reddy Pavan; Sun Yaping; Toubai Tomomi; Duran-Struuck Raimon; Clouthier Shawn G; Weisiger Elizabeth; Maeda Yoshinobu; Tawara Isao; Krijanovski Oleg; Gatza Erin; Liu Chen; Malter Chelsea; Mascagni Paolo; Dinarello Charles A; Ferrara James L M
Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.
The Journal of clinical investigation 2008;118(7):2562-73.
-
2008: Kitko Carrie L; Paczesny Sophie; Yanik Gregory; Braun Thomas; Jones Dawn; Whitfield Joel; Choi Sung W; Hutchinson Raymond J; Ferrara James L M; Levine John E
Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):759-65.
-
2008: Flierl Michael A; Rittirsch Daniel; Gao Hongwei; Hoesel Laszlo M; Nadeau Brian A; Day Danielle E; Zetoune Firas S; Sarma J Vidya; Huber-Lang Markus S; Ferrara James L M; Ward Peter A
Adverse functions of IL-17A in experimental sepsis.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(7):2198-205.
-
2008: Chao Mwe Mwe; Levine John E; Ferrara James L; Cooling Laura; Cooke Kenneth R; Hutchinson Raymond J; Yanik Gregory A
Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H.
Pediatric blood & cancer 2008;50(4):917-9.
-
2008: Levine John E; Paczesny Sophie; Mineishi Shin; Braun Thomas; Choi Sung W; Hutchinson Raymond J; Jones Dawn; Khaled Yasser; Kitko Carrie L; Bickley Daniel; Krijanovski Oleg; Reddy Pavan; Yanik Gregory; Ferrara James L M
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.
Blood 2008;111(4):2470-5.
-
2007: Duran-Struuck Raimon; Tawara Isao; Lowler Kathi; Clouthier Shawn G; Weisiger Elizabeth; Rogers Clare; Luker Gary; Kumanogoh Atsushi; Liu Chen; Ferrara James L M; Reddy Pavan
A novel role for the semaphorin Sema4D in the induction of allo-responses.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(11):1294-1303.
-
2007: Ferrara James L M; Anasetti Claudio; Stadtmauer Edward; Antin Joseph; Wingard John; Lee Stephanie; Levine John; Schultz Kirk; Appelbaum Frederick; Negrin Robert; Giralt Sergio; Bredeson Christopher; Heslop Helen; Horowitz Mary
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(11):1268-85.
-
2007: Khaled Y; Kato K; Janakiraman N; Ferrara J L M; Mineishi S
Early relapses do not impact survival after autologous stem cell transplantation in African Americans with multiple myeloma.
Bone marrow transplantation 2007;39(11):727-8.
-
2007: Weissinger Eva M; Schiffer Eric; Hertenstein Bernd; Ferrara James L; Holler Ernst; Stadler Michael; Kolb Hans-Jochem; Zander Axel; Zürbig Petra; Kellmann Markus; Ganser Arnold
Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Blood 2007;109(12):5511-9.
-
2007: Ferrara James L M
Novel strategies for the treatment and diagnosis of graft-versus-host-disease.
Best practice & research. Clinical haematology 2007;20(1):91-7.
-
2007: Kharfan-Dabaja Mohamed A; Anasetti Claudio; Ferrara James L M
Sympathectomy protects denervated skin from graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):369-70.
-
2007: Weisdorf Daniel; Carter Shelly; Confer Dennis; Ferrara James; Horowitz Mary
Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):257-62; discussion 255-6.
-
2006: Blazar Bruce R; Weisdorf Daniel J; Defor Todd; Goldman Anne; Braun Thomas; Silver Samuel; Ferrara James L M
Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).
Blood 2006;108(9):3216-22.
-
2006: Greinix H T; Socié G; Bacigalupo A; Holler E; Edinger M G; Apperley J F; Schwarz T; Ullrich S E; Albert M L; Knobler R M; Peritt D; Ferrara J L M
Assessing the potential role of photopheresis in hematopoietic stem cell transplant.
Bone marrow transplantation 2006;38(4):265-73.
-
2006: Abbasian Javaneh; Mahmud Dolores; Mahmud Nadim; Chunduri Sandeep; Araki Hiroto; Reddy Pavan; Hoffman Ronald; Arpinati Mario; Ferrara James L M; Rondelli Damiano
Allogeneic T cells induce rapid CD34+ cell differentiation into CD11c+CD86+ cells with direct and indirect antigen-presenting function.
Blood 2006;108(1):203-8.
-
2006: Rizzo J Douglas; Wingard John R; Tichelli Andre; Lee Stephanie J; Van Lint Maria Teresa; Burns Linda J; Davies Stella M; Ferrara James L M; Socié Gérard
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):138-51.
-
2006: Schultz Kirk R; Miklos David B; Fowler Daniel; Cooke Ken; Shizuru Judith; Zorn Emmanuel; Holler Ernst; Ferrara James; Shulman Howard; Lee Stephanie J; Martin Paul; Filipovich Alexandra H; Flowers Mary E D; Weisdorf Daniel; Couriel Daniel; Lachenbruch Peter A; Mittleman Barbara; Vogelsang Georgia B; Pavletic Steven Z
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):126-37.
-
2006: Rizzo J D; Wingard J R; Tichelli A; Lee S J; Van Lint M T; Burns L J; Davies S M; Ferrara J L M; Socié G
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT).
Bone marrow transplantation 2006;37(3):249-61.
-
2006: Ferrara James L M; Reddy Pavan
Pathophysiology of graft-versus-host disease.
Seminars in hematology 2006;43(1):3-10.
-
2006: Ferrara James L M; Levine John E
Graft-versus-host disease in the 21st century: new perspectives on an old problem.
Seminars in hematology 2006;43(1):1-2.
-
2005: Reddy Pavan; Maeda Yoshinobu; Liu Chen; Krijanovski Oleg I; Korngold Robert; Ferrara James L M
A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses.
Nature medicine 2005;11(11):1244-9.
-
2005: Choi S W; Islam S; Greenson J K; Levine J; Hutchinson R; Yanik G; Teitelbaum D H; Ferrara J L M; Cooke K R
The use of laparoscopic liver biopsies in pediatric patients with hepatic dysfunction following allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2005;36(10):891-6.
-
2005: Kassim A A; Chinratanalab W; Ferrara J L M; Mineishi S
Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: 'what is the best recipe?'.
Bone marrow transplantation 2005;36(7):565-74.
-
2005: Uberti Joseph P; Ayash Lois; Ratanatharathorn Voravit; Silver Samuel; Reynolds Christopher; Becker Michael; Reddy Pavan; Cooke Kenneth R; Yanik Gregory; Whitfield Joel; Jones Dawn; Hutchinson Raymond; Braun Thomas; Ferrara James L M; Levine John E
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(9):680-7.
-
2005: Hassan Adam S; Clouthier Shawn G; Ferrara James L M; Stepan Alexandra; Mian Shahzad I; Ahmad Amjad Z; Elner Victor M
Lacrimal gland involvement in graft-versus-host disease: a murine model.
Investigative ophthalmology & visual science 2005;46(8):2692-7.
-
2005: Ho Vincent T; Cutler Corey; Carter Shelly; Martin Paul; Adams Roberta; Horowitz Mary; Ferrara James; Soiffer Robert; Giralt Sergio
Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(8):571-5.
-
2005: Maeda Yoshinobu; Reddy Pavan; Lowler Kathleen P; Liu Chen; Bishop Dennis Keith; Ferrara James L M
Critical role of host gammadelta T cells in experimental acute graft-versus-host disease.
Blood 2005;106(2):749-55.
-
2005: Ferrara James L M; Yanik Gregory
Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies.
Clinical advances in hematology & oncology : H&O 2005;3(5):415-9, 428.
-
2005: Wang Hong; Clouthier Shawn G; Galchev Vladimir; Misek David E; Duffner Ulrich; Min Chang-Ki; Zhao Rong; Tra John; Omenn Gilbert S; Ferrara James L M; Hanash Samir M
Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids.
Molecular & cellular proteomics : MCP 2005;4(5):618-25.
-
2005: Sabel Michael S; Nehs Matthew A; Su Gang; Lowler Kathleen P; Ferrara James L M; Chang Alfred E
Immunologic response to cryoablation of breast cancer.
Breast cancer research and treatment 2005;90(1):97-104.
-
2005: Choi S W; Boxer L A; Pulsipher M A; Roulston D; Hutchinson R J; Yanik G A; Cooke K R; Ferrara J L M; Levine J E
Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation.
Bone marrow transplantation 2005;35(5):473-7.
-
2005: Maeda Yoshinobu; Levy Robert B; Reddy Pavan; Liu Chen; Clouthier Shawn G; Teshima Takanori; Ferrara James L M
Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease.
Blood 2005;105(5):2023-7.
-
2005: MacDonald Kelli P A; Rowe Vanessa; Clouston Andrew D; Welply Joseph K; Kuns Rachel D; Ferrara James L M; Thomas Ranjeny; Hill Geoffrey R
Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(4):1841-50.
-
2005: Szczypka Mark S; Westover Angela J; Clouthier Shawn G; Ferrara James L M; Humes H David
Rare incorporation of bone marrow-derived cells into kidney after folic acid-induced injury.
Stem cells (Dayton, Ohio) 2005;23(1):44-54.
-
2004: Auletta Jeffery J; Devecchio Jennifer L; Ferrara James L M; Heinzel Frederick P
Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):834-47.
-
2004: Min Chang-Ki; Maeda Yoshinobu; Lowler Kathleen; Liu Chen; Clouthier Shawn; Lofthus David; Weisiger Elizabeth; Ferrara James L M; Reddy Pavan
Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.
Blood 2004;104(10):3393-9.
-
2004: Gerbitz Armin; Nickoloff Brian J; Olkiewicz Krystyna; Willmarth Nicole E; Hildebrandt Gerhard; Liu Chen; Kobzik Lester; Eissner Günther; Holler Ernst; Ferrara James L M; Cooke Kenneth R
A role for tumor necrosis factor-alpha-mediated endothelial apoptosis in the development of experimental idiopathic pneumonia syndrome.
Transplantation 2004;78(4):494-502.
-
2004: Duffner Ulrich A; Maeda Yoshinobu; Cooke Kenneth R; Reddy Pavan; Ordemann Rainer; Liu Chen; Ferrara James L M; Teshima Takanori
Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(12):7393-8.
-
2004: MacDonald Kelli P A; Rowe Vanessa; Filippich Cheryl; Johnson Diana; Morris Edward S; Clouston Andrew D; Ferrara James L M; Hill Geoffrey R
Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(6):373-85.
-
2004: Hofmeister Craig C; Quinn Adam; Cooke Kenneth R; Stiff Patrick; Nickoloff Brian; Ferrara James L M
Graft-versus-host disease of the skin: life and death on the epidermal edge.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(6):366-72.
-
2004: Reddy Pavan; Maeda Yoshinobu; Hotary Kevin; Liu Chen; Reznikov Leonid L; Dinarello Charles A; Ferrara James L M
Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(11):3921-6.
-
2004: Reddy P; Davenport R; Ratanatharathorn V; Reynolds C; Silver S; Ayash L; Ferrara J L M; Uberti J P
West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation.
Bone marrow transplantation 2004;33(1):109-12.
-
2003: Braun Thomas M; Levine John E; Ferrara James L M
Determining a maximum tolerated cumulative dose: dose reassignment within the TITE-CRM.
Controlled clinical trials 2003;24(6):669-81.
-
2003: Cooke Kenneth R; Ferrara James L M
A protective gene for graft-versus-host disease.
The New England journal of medicine 2003;349(23):2183-4.
-
2003: Reddy Pavan; Ferrara James L M
Immunobiology of acute graft-versus-host disease.
Blood reviews 2003;17(4):187-94.
-
2003: Ferrara James L M; Cooke Kenneth R; Teshima Takanori
The pathophysiology of acute graft-versus-host disease.
International journal of hematology 2003;78(3):181-7.
-
2003: Duffner Ulrich; Lu Bao; Hildebrandt Gerhard C; Teshima Takanori; Williams Debra L; Reddy Pavan; Ordemann Rainer; Clouthier Shawn G; Lowler Kathy; Liu Chen; Gerard Craig; Cooke Kenneth R; Ferrara James L M
Role of CXCR3-induced donor T-cell migration in acute GVHD.
Experimental hematology 2003;31(10):897-902.
-
2003: Clouthier Shawn G; Cooke Kenneth R; Teshima Takanori; Lowler Kathleen P; Liu Chen; Connolly Kevin; Ferrara James L M
Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(9):592-603.
-
2003: Ratanatharathorn Voravit; Ayash Lois; Reynolds Christopher; Silver Samuel; Reddy Pavan; Becker Michael; Ferrara James L M; Uberti Joseph P
Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(8):505-11.
-
2003: Ichiba Tamotsu; Teshima Takanori; Kuick Rork; Misek David E; Liu Chen; Takada Yuichiro; Maeda Yoshinobu; Reddy Pavan; Williams Debra L; Hanash Samir M; Ferrara James L M
Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays.
Blood 2003;102(2):763-71.
-
2003: Teshima Takanori; Reddy Pavan; Liu Chen; Williams Debra; Cooke Kenneth R; Ferrara James L M
Impaired thymic negative selection causes autoimmune graft-versus-host disease.
Blood 2003;102(2):429-35.
-
2003: Reddy Pavan; Ferrara James L M
Role of interleukin-18 in acute graft-vs-host disease.
The Journal of laboratory and clinical medicine 2003;141(6):365-71.
-
2003: Reddy Pavan; Teshima Takanori; Hildebrandt Gerhard; Williams Debra L; Liu Chen; Cooke Kenneth R; Ferrara James L M
Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects.
Blood 2003;101(7):2877-85.
-
2003: Levine John E; Uberti Joseph P; Ayash Lois; Reynolds Christopher; Ferrara James L m; Silver Samuel M; Braun Thomas; Yanik Gregory; Hutchinson Raymond; Ratanatharathorn Voravit
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(3):189-97.
-
2003: MacDonald Kelli P A; Rowe Vanessa; Filippich Cheryl; Thomas Ranjeny; Clouston Andrew D; Welply Joseph K; Hart Derek N J; Ferrara James L M; Hill Geoffrey R
Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
Blood 2003;101(5):2033-42.
-
2003: Ferrara James
Location, location, location.
Nature immunology 2003;4(2):103-4.
-
2002: DiNubile Mark J; Stossel Thomas P; Ljunghusen Olof C; Ferrara James L M; Antin Joseph H
Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation.
Blood 2002;100(13):4367-71.
-
2002: Antin Joseph H; Weisdorf Daniel; Neuberg Donna; Nicklow Roberta; Clouthier Shawn; Lee Stephanie J; Alyea Edwin; McGarigle Carol; Blazar Bruce R; Sonis Stephen; Soiffer Robert J; Ferrara James L M
Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation.
Blood 2002;100(10):3479-82.
-
2002: Reddy Pavan; Teshima Takanori; Hildebrandt Gerhard; Duffner Ulrich; Maeda Yoshinobu; Cooke Kenneth R; Ferrara James L M
Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation.
Blood 2002;100(9):3429-31.
-
2002: Ferrara James L M
Cellular and cytokine effectors of acute graft versus host disease.
International journal of hematology 2002;76 Suppl 1():195-8.
-
2002: Trask P C; Paterson A; Riba M; Brines B; Griffith K; Parker P; Weick J; Steele P; Kyro K; Ferrara J
Assessment of psychological distress in prospective bone marrow transplant patients.
Bone marrow transplantation 2002;29(11):917-25.
-
2002: Teshima Takanori; Ordemann Rainer; Reddy Pavan; Gagin Svetlana; Liu Chen; Cooke Kenneth R; Ferrara James L M
Acute graft-versus-host disease does not require alloantigen expression on host epithelium.
Nature medicine 2002;8(6):575-81.
-
2002: Clouthier Shawn G; Ferrara James L M; Teshima Takanori
Graft-versus-host disease in the absence of the spleen after allogeneic bone marrow transplantation.
Transplantation 2002;73(10):1679-81.
-
2002: Ordemann Rainer; Hutchinson Raymond; Friedman Jeffrey; Burakoff Steven J; Reddy Pavan; Duffner Ulrich; Braun Thomas M; Liu Chen; Teshima Takanori; Ferrara James L M
Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease.
The Journal of clinical investigation 2002;109(9):1249-56.
-
2002: Yanik Gregory A; Levine John E; Matthay Katherine K; Sisson James C; Shulkin Barry L; Shapiro Brahm; Hubers David; Spalding Susan; Braun Tom; Ferrara James L M; Hutchinson Raymond J
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2142-9.
-
2002: Antin J H; Lee S J; Neuberg D; Alyea E; Soiffer R J; Sonis S; Ferrara J L M
A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation.
Bone marrow transplantation 2002;29(5):373-7.
-
2002: Teshima Takanori; Reddy Pavan; Lowler Kathleen P; KuKuruga Mark A; Liu Chen; Cooke Kenneth R; Ferrara James L M
Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease.
Blood 2002;99(5):1825-32.
-
2002: Teshima Takanori; Liu Chen; Lowler Kathleen P; Dranoff Glenn; Ferrara James L M
Donor leukocyte infusion from immunized donors increases tumor vaccine efficacy after allogeneic bone marrow transplantation.
Cancer research 2002;62(3):796-800.
-
2002: Teshima Takanori; Ferrara James L M
Understanding the alloresponse: new approaches to graft-versus-host disease prevention.
Seminars in hematology 2002;39(1):15-22.
-
2002: Cooke Kenneth R; Olkiewicz Krystyna; Erickson Nicole; Ferrara James L M
The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease.
Journal of endotoxin research 2002;8(6):441-8.
-
2002: Ferrara James L M; Schmaier Alvin H
Hematology grants workshop.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():484-9.
-
2002: Yanik Gregory; Hellerstedt Beth; Custer Joseph; Hutchinson Raymond; Kwon Deborah; Ferrara James L M; Uberti Joseph; Cooke Kenneth R
Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(7):395-400.
-
2002: Ferrara James L M; Wingard John R
Clinical research: the best or worst of times?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(6):293-4.
-
2001: Ayash L J; Clarke M; Adams P; Ferrara J; Ratanatharathorn V; Reynolds C; Roessler B; Silver S; Strawderman M; Uberti J; Wicha M
Clinical protocol. Purging of autologous stem cell sources with bcl-x(s) adenovirus for women undergoing high-dose chemotherapy for stage IV breast carcinoma.
Human gene therapy 2001;12(16):2023-5.
-
2001: Reddy P; Teshima T; Kukuruga M; Ordemann R; Liu C; Lowler K; Ferrara J L
Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis.
The Journal of experimental medicine 2001;194(10):1433-40.
-
2001: Cooke K R; Gerbitz A; Crawford J M; Teshima T; Hill G R; Tesolin A; Rossignol D P; Ferrara J L
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.
The Journal of clinical investigation 2001;107(12):1581-9.
-
2001: Ayash L J; Clarke M; Silver S M; Braun T; Uberti J; Ratanatharathorn V; Reynolds C; Ferrara J; Broun E R; Adams P T
Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.
Bone marrow transplantation 2001;27(9):939-47.
-
2001: Schmaltz C; Alpdogan O; Horndasch K J; Muriglan S J; Kappel B J; Teshima T; Ferrara J L; Burakoff S J; van den Brink M R
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.
Blood 2001;97(9):2886-95.
-
2001: Reynolds C; Ratanatharathorn V; Adams P; Braun T; Silver S; Ayash L; Carson E; Eisbruch A; Dawson L A; McDonagh K; Ferrara J; Uberti J
Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.
Bone marrow transplantation 2001;27(8):801-7.
-
2001: Padovan C S; Gerbitz A; Sostak P; Holler E; Ferrara J L; Bise K; Straube A
Cerebral involvement in graft-versus-host disease after murine bone marrow transplantation.
Neurology 2001;56(8):1106-8.
-
2001: Teshima T; Mach N; Hill G R; Pan L; Gillessen S; Dranoff G; Ferrara J L
Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation.
Cancer research 2001;61(1):162-71.
-
2001: van Os R; Sheridan T M; Robinson S; Drukteinis D; Ferrara J L; Mauch P M
Immunogenicity of Ly5 (CD45)-antigens hampers long-term engraftment following minimal conditioning in a murine bone marrow transplantation model.
Stem cells (Dayton, Ohio) 2001;19(1):80-7.
-
2000: Cooke K R; Hill G R; Gerbitz A; Kobzik L; Martin T R; Crawford J M; Brewer J P; Ferrara J L
Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammation.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(11):6612-9.
-
2000: Ratanatharathorn V; Carson E; Reynolds C; Ayash L J; Levine J; Yanik G; Silver S M; Ferrara J L; Uberti J P
Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease.
Annals of internal medicine 2000;133(4):275-9.
-
2000: Cooke K R; Hill G R; Gerbitz A; Kobzik L; Martin T R; Crawford J M; Brewer J P; Ferrara J L
Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation.
Transplantation 2000;70(2):272-9.
-
2000: Yanik G; Levine J E; Ratanatharathorn V; Dunn R; Ferrara J; Hutchinson R J
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
Bone marrow transplantation 2000;26(2):161-7.
-
2000: Ferrara J L
Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors.
Journal of hematotherapy & stem cell research 2000;9(3):299-306.
-
2000: Hill G R; Ferrara J L
The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.
Blood 2000;95(9):2754-9.
-
2000: Ferrara J L
Cytokines and the regulation of tolerance.
The Journal of clinical investigation 2000;105(8):1043-4.
-
2000: Reddy V; Hill G R; Pan L; Gerbitz A; Teshima T; Brinson Y; Ferrara J L
G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient.
Transplantation 2000;69(4):691-3.
-
2000: van den Brink M R; Moore E; Ferrara J L; Burakoff S J
Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity.
Transplantation 2000;69(3):446-9.
-
2000: Hill G R; Teshima T; Rebel V I; Krijanovski O I; Cooke K R; Brinson Y S; Ferrara J L
The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(2):656-63.
-
2000: Sturm E; Zimmerman T L; Crawford A R; Svetlov S I; Sundaram P; Ferrara J L; Karpen S J; Crawford J M
Endotoxin-stimulated macrophages decrease bile acid uptake in WIF-B cells, a rat hepatoma hybrid cell line.
Hepatology (Baltimore, Md.) 2000;31(1):124-30.
-
1999: McKay D B; Irie H Y; Hollander G; Ferrara J L; Strom T B; Li Y; Burakoff S J
Antigen-induced unresponsiveness results in altered T cell signaling.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(12):6455-61.
-
1999: Rebel V I; Hartnett S; Hill G R; Lazo-Kallanian S B; Ferrara J L; Sieff C A
Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level.
The Journal of experimental medicine 1999;190(10):1493-504.
-
1999: Hill G R; Teshima T; Gerbitz A; Pan L; Cooke K R; Brinson Y S; Crawford J M; Ferrara J L
Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.
The Journal of clinical investigation 1999;104(4):459-67.
-
1999: Teshima T; Hill G R; Pan L; Brinson Y S; van den Brink M R; Cooke K R; Ferrara J L
IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
The Journal of clinical investigation 1999;104(3):317-25.
-
1999: Krijanovski O I; Hill G R; Cooke K R; Teshima T; Crawford J M; Brinson Y S; Ferrara J L
Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease.
Blood 1999;94(2):825-31.
-
1999: Hill G R; Cooke K R; Brinson Y S; Bungard D; Ferrara J L
Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation.
Transplantation 1999;67(11):1478-80.
-
1999: Pan L; Teshima T; Hill G R; Bungard D; Brinson Y S; Reddy V S; Cooke K R; Ferrara J L
Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease.
Blood 1999;93(12):4071-8.
-
1999: Grass J A; Wafa T; Reames A; Wages D; Corash L; Ferrara J L; Lin L
Prevention of transfusion-associated graft-versus-host disease by photochemical treatment.
Blood 1999;93(9):3140-7.
-
1999: Ferrara J L; Holler E; Blazar B
Monoclonal antibody and receptor antagonist therapy for GVHD.
Cancer treatment and research 1999;101():331-68.
-
1999: Ferrara J L; Levy R; Chao N J
Pathophysiologic mechanisms of acute graft-vs.-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(6):347-56.
-
1998: Cooke K R; Hill G R; Crawford J M; Bungard D; Brinson Y S; Delmonte J; Ferrara J L
Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.
The Journal of clinical investigation 1998;102(10):1882-91.
-
1998: Cooke K R; Krenger W; Hill G; Martin T R; Kobzik L; Brewer J; Simmons R; Crawford J M; van den Brink M R; Ferrara J L
Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation.
Blood 1998;92(7):2571-80.
-
1998: Hill G R; Cooke K R; Teshima T; Crawford J M; Keith J C; Brinson Y S; Bungard D; Ferrara J L
Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.
The Journal of clinical investigation 1998;102(1):115-23.
-
1998: Ferrara J L
The cytokine modulation of acute graft-versus-host disease.
Bone marrow transplantation 1998;21 Suppl 3():S13-5.
-
1998: Ferrara J L; Krenger W
Graft-versus-host disease: the influence of type 1 and type 2 T cell cytokines.
Transfusion medicine reviews 1998;12(1):1-17.
-
1998: Dunussi-Joannopoulos K; Dranoff G; Weinstein H J; Ferrara J L; Bierer B E; Croop J M
Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines.
Blood 1998;91(1):222-30.
-
1997: Hill G R; Krenger W; Ferrara J L
The role of cytokines in acute graft-versus-host disease.
Cytokines, cellular & molecular therapy 1997;3(4):257-66.
-
1997: Ballen K K; Gilliland D G; Guinan E C; Hsieh C C; Parsons S K; Rimm I J; Ferrara J L; Bierer B E; Weinstein H J; Antin J H
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia.
Bone marrow transplantation 1997;20(9):737-43.
-
1997: Cooke K R; Nishinakamura R; Martin T R; Kobzik L; Brewer J; Whitsett J A; Bungard D; Murray R; Ferrara J L
Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 beta c receptor-deficient mice despite correction of alveolar proteinosis after BMT.
Bone marrow transplantation 1997;20(8):657-62.
-
1997: Hill G R; Crawford J M; Cooke K R; Brinson Y S; Pan L; Ferrara J L
Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.
Blood 1997;90(8):3204-13.
-
1997: Krenger W; Hill G R; Ferrara J L
Cytokine cascades in acute graft-versus-host disease.
Transplantation 1997;64(4):553-8.
-
1997: Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder J P; Mazanet R; Ferrara J; Rimm I J; Guinan E; Bierer B; Gilliland G; Churchill W H; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(2):98-106.
-
1997: Dunussi-Joannopoulos K; Krenger W; Weinstein H J; Ferrara J L; Croop J M
CD8+ T cells activated during the course of murine acute myelogenous leukemia elicit therapeutic responses to late B7 vaccines after cytoreductive treatment.
Blood 1997;89(8):2915-24.
-
1997: Schwaighofer H; Oberhuber G; Hebart H; Einsele H; Herold M; Nachbaur D; Eibl B; Tilg H; Kropshofer G; Ferrara J L; Niederwieser D
Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy.
Transplantation 1997;63(1):52-6.
-
1996: Porter D L; Roth M S; Lee S J; McGarigle C; Ferrara J L; Antin J H
Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.
Bone marrow transplantation 1996;18(5):975-80.
-
1996: Krenger W; Cooke K R; Crawford J M; Sonis S T; Simmons R; Pan L; Delmonte J; Karandikar M; Ferrara J L
Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease.
Transplantation 1996;62(9):1278-85.
-
1996: Pan L; Bressler S; Cooke K R; Krenger W; Karandikar M; Ferrara J L
Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(3):126-33.
-
1996: Cooke K R; Kobzik L; Martin T R; Brewer J; Delmonte J; Crawford J M; Ferrara J L
An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin.
Blood 1996;88(8):3230-9.
-
1996: Ferrara J L; Cooke K R; Pan L; Krenger W
The immunopathophysiology of acute graft-versus-host-disease.
Stem cells (Dayton, Ohio) 1996;14(5):473-89.
-
1996: Krenger W; Falzarano G; Delmonte J; Snyder K M; Byon J C; Ferrara J L
Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease.
Blood 1996;88(3):1113-21.
-
1996: Rimm I J; Krenger W; Beland J L; Geller M C; Di Savino E; Yui K; Katsumata M; Ferrara J L
TCR-beta transgenic mice fail to mediate a GVHR due to defects of allorecognition and subsequent IL-2 generation.
Bone marrow transplantation 1996;17(5):835-42.
-
1996: Tan K N; Min H K; Pan L; Ferrara J L; Myrick K V
Biological characteristics of an immunoregulatory activity secreted by an autoreactive CD4+ T cell clone that suppresses autoimmune diabetes in non-obese diabetic mice.
International immunology 1996;8(5):689-99.
-
1996: Falzarano G; Krenger W; Snyder K M; Delmonte J; Karandikar M; Ferrara J L
Suppression of B-cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-alpha in mice with acute graft-versus-host disease.
Blood 1996;87(7):2853-60.
-
1996: Krenger W; Ferrara J L
Dysregulation of cytokines during graft-versus-host disease.
Journal of hematotherapy 1996;5(1):3-14.
-
1996: Krenger W; Ferrara J L
Graft-versus-host disease and the Th1/Th2 paradigm.
Immunologic research 1996;15(1):50-73.
-
1995: Ferrara J L
Cytokine inhibitors and graft-versus-host disease.
Annals of the New York Academy of Sciences 1995;770():227-36.
-
1995: Pan L; Delmonte J; Jalonen C K; Ferrara J L
Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease.
Blood 1995;86(12):4422-9.
-
1995: Akhtar I; Gold J P; Pan L Y; Ferrara J L; Yang X D; Kim J I; Tan K N
CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice.
The Journal of experimental medicine 1995;182(1):87-97.
-
1995: Krenger W; Snyder K M; Byon J C; Falzarano G; Ferrara J L
Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(2):585-93.
-
1995: Ferrara J L
The febrile platelet transfusion reaction: a cytokine shower.
Transfusion 1995;35(2):89-90.
-
1994: Krenger W; Snyder K; Smith S; Ferrara J L
Effects of exogenous interleukin-10 in a murine model of graft-versus-host disease to minor histocompatibility antigens.
Transplantation 1994;58(11):1251-7.
-
1994: Ferrara J L
Cellular and molecular mechanisms of graft-versus-host disease.
Transfusion science 1994;15(3):197-206.
-
1994: Rimm I J; Fruman D A; Abhyankar S; Sakamoto H; Orme I M; Milstone D; Seidman J G; Ferrara J L
T cell receptor (beta chain) transgenic mice have selective deficits in gamma delta T cell subpopulations.
Transplant immunology 1994;2(3):218-24.
-
1994: Ferrara J L
Paradigm shift for graft-versus-host disease.
Bone marrow transplantation 1994;14(2):183-4.
-
1994: Wilson R B; Ferrara J L; Baum H J; Shaler R C
Guidelines for internal validation of the HLA-DQ alpha DNA typing system.
Forensic science international 1994;66(1):9-22.
-
1994: Neben S; Donaldson D; Sieff C; Mauch P; Bodine D; Ferrara J; Yetz-Aldape J; Turner K
Synergistic effects of interleukin-11 with other growth factors on the expansion of murine hematopoietic progenitors and maintenance of stem cells in liquid culture.
Experimental hematology 1994;22(4):353-9.
-
1994: Ferrara J L
Cytokines other than growth factors in bone marrow transplantation.
Current opinion in oncology 1994;6(2):127-34.
-
1994: Porter D L; Roth M S; McGarigle C; Ferrara J L; Antin J H
Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.
The New England journal of medicine 1994;330(2):100-6.
-
1993: Abhyankar S; Gilliland D G; Ferrara J L
Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens.
Transplantation 1993;56(6):1518-23.
-
1993: Ferrara J L
Cytokine dysregulation as a mechanism of graft versus host disease.
Current opinion in immunology 1993;5(5):794-9.
-
1993: Ferrara J L; Abhyankar S; Gilliland D G
Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
Transplantation proceedings 1993;25(1 Pt 2):1216-7.
-
1993: Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P;
Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Experimental hematology 1993;21(1):156-62.
-
1993: Araten D J; Lawton T; Ferrara J; Antin J H; Milford E; Carpenter C B; Maziarz R T
In vitro alloreactivity against host antigens in an adult HLA-mismatched bone marrow transplant recipient despite in vivo host tolerance.
Transplantation 1993;55(1):76-82.
-
1992: Antin J H; Ferrara J L
Cytokine dysregulation and acute graft-versus-host disease.
Blood 1992;80(12):2964-8.
-
1992: Down J D; Mauch P; Warhol M; Neben S; Ferrara J L
The effect of donor T lymphocytes and total-body irradiation on hemopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transplantation.
Transplantation 1992;54(5):802-8.
-
1992: Ferrara J L
Advances in GVHD: novel lymphocyte subsets and cytokine dysregulation.
Bone marrow transplantation 1992;10 Suppl 1():10-2.
-
1991: Sakamoto H; Michaelson J; Jones W K; Bhan A K; Abhyankar S; Silverstein M; Golan D E; Burakoff S J; Ferrara J L
Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(23):10890-4.
-
1991: van Dijken P J; Wimperis J; Crawford J M; Ferrara J L
Effect of graft-versus-host disease on hematopoiesis after bone marrow transplantation in mice.
Blood 1991;78(10):2773-9.
-
1991: McCarthy P L; Abhyankar S; Neben S; Newman G; Sieff C; Thompson R C; Burakoff S J; Ferrara J L
Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease.
Blood 1991;78(8):1915-8.
-
1991: Antin J H; Bierer B E; Smith B R; Ferrara J; Guinan E C; Sieff C; Golan D E; Macklis R M; Tarbell N J; Lynch E
Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies.
Blood 1991;78(8):2139-49.
-
1991: Ferrara J L; Deeg H J
Graft-versus-host disease.
The New England journal of medicine 1991;324(10):667-74.
-
1991: Rimm I J; Ghayur T; Gasser D L; Rosenkrantz K; Burakoff S J; Seidman J G; Ferrara J L
Alloreactive lymphocytes from T cell receptor (beta-chain) transgenic mice do not mediate a graft-versus-host reaction.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(4):1130-3.
-
1990: Blatter D D; Crawford J M; Ferrara J L
Nuclear magnetic resonance of hepatic graft-versus-host disease in mice.
Transplantation 1990;50(6):1011-8.
-
1990: van Dijken P J; Ghayur T; Mauch P; Down J; Burakoff S J; Ferrara J L
Evidence that anti-LFA-1 in vivo improves engraftment and survival after allogeneic bone marrow transplantation.
Transplantation 1990;49(5):882-6.
-
1990: Ferrara J L; Mauch P; Van Dijken P J; Crosier K E; Michaelson J; Burakoff S J
Evidence that anti-asialo GM1 in vivo improves engraftment of T cell-depleted bone marrow in hybrid recipients.
Transplantation 1990;49(1):134-8.
-
1990: Antin J H; Bierer B E; Smith B R; Guinan E C; Provost M M; Ferrara J; Macklis R M; Tarbell N J; Blythman H; Bouloux C
Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin): effective prophylaxis for graft-versus-host disease.
Progress in clinical and biological research 1990;333():207-15.
-
1989: Mauch P; Ferrara J; Hellman S
Stem cell self-renewal considerations in bone marrow transplantation.
Bone marrow transplantation 1989;4(6):601-7.
-
1989: Emerson S G; Thomas S; Ferrara J L; Greenstein J L
Developmental regulation of erythropoiesis by hematopoietic growth factors: analysis on populations of BFU-E from bone marrow, peripheral blood, and fetal liver.
Blood 1989;74(1):49-55.
-
1989: Down J D; Berman A J; Warhol M; Van Dijken P J; Ferrara J L; Yeap B; Hellman S; Mauch P M
Late tissue-specific toxicity of total body irradiation and busulfan in a murine bone marrow transplant model.
International journal of radiation oncology, biology, physics 1989;17(1):109-16.
-
1989: Wall D A; Hamberg S; Ferrara J L; Abbas A K
Immunodeficiency in graft-versus-host disease (GVHD). II. Effects of GVHD-induced suppressor cells on CD4+ T cell clones.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(1):74-8.
-
1989: Macklis R M; Kaplan W D; Ferrara J L; Atcher R W; Hines J J; Burakoff S J; Coleman C N
Alpha particle radio-immunotherapy: animal models and clinical prospects.
International journal of radiation oncology, biology, physics 1989;16(6):1377-87.
-
1989: Ferrara J L; Guillen F J; van Dijken P J; Marion A; Murphy G F; Burakoff S J
Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease.
Transplantation 1989;47(1):50-4.
-
1988: Macklis R M; Kaplan W D; Ferrara J L; Kinsey B M; Kassis A I; Burakoff S J
Biodistribution studies of anti-Thy 1.2 IgM immunoconjugates: implications for radioimmunotherapy.
International journal of radiation oncology, biology, physics 1988;15(2):383-9.
-
1988: Ferrara J L; Michaelson J; Burakoff S J; Mauch P
Engraftment following T cell-depleted bone marrow transplantation. III. Differential effects of increased total-body irradiation on semiallogeneic and allogeneic recipients.
Transplantation 1988;45(5):948-52.
-
1988: Wall D A; Hamberg S D; Reynolds D S; Burakoff S J; Abbas A K; Ferrara J L
Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(9):2970-6.
-
1988: Macklis R M; Kinsey B M; Kassis A I; Ferrara J L; Atcher R W; Hines J J; Coleman C N; Adelstein S J; Burakoff S J
Radioimmunotherapy with alpha-particle-emitting immunoconjugates.
Science (New York, N.Y.) 1988;240(4855):1024-6.
-
1988: Kinsey B M; Macklis R M; Ferrara J M; Layne W W; Burakoff S J; Kassis A I
Efficient conjugation of DTPA to an IgM monoclonal antibody in ascites fluid.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(3):285-92.
-
1987: Holcombe R F; Strauss W; Owen F L; Boxer L A; Warren R W; Conley M E; Ferrara J; Leavitt R Y; Fauci A S; Taylor B A
Relationship of the genes for Chediak-Higashi syndrome (beige) and the T-cell receptor gamma chain in mouse and man.
Genomics 1987;1(3):287-91.
-
1987: Ferrara J L; Mauch P; McIntyre J; Michaelson J; Burakoff S J
Engraftment following T-cell-depleted bone marrow transplantation. II. Stability of mixed chimerism in semiallogeneic recipients after total-body irradiation.
Transplantation 1987;44(4):495-9.
-
1987: Ferrara J L
Syngeneic graft-vs-host disease.
Archives of dermatology 1987;123(6):741-2.
-
1987: Ferrara J L; Daley J P; Burakoff S J; Miller R A
Functional T cell deficits after bone marrow transplantation across minor histocompatibility barriers: effects of graft-vs-host disease on precursor frequency of reactive cells.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(11):3598-603.
-
1987: Ferrara J; Lipton J; Hellman S; Burakoff S; Mauch P
Engraftment following T-cell-depleted marrow transplantation. I. The role of major and minor histocompatibility barriers.
Transplantation 1987;43(4):461-7.
-
1987: Ferrara J; Marion A; Murphy G; Burakoff S
Acute graft-versus-host disease: pathogenesis and prevention with a monoclonal antibody in vivo.
Transplantation proceedings 1987;19(1 Pt 3):2662-3.
-
1986: Ferrara J L; Marion A; McIntyre J F; Murphy G F; Burakoff S J
Amelioration of acute graft vs host disease due to minor histocompatibility antigens by in vivo administration of anti-interleukin 2 receptor antibody.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(6):1874-7.
-
1986: Guillén F J; Ferrara J; Hancock W W; Messadi D; Fonferko E; Burakoff S J; Murphy G F
Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model. Evidence that large granular lymphocytes are effector cells in the immune response.
Laboratory investigation; a journal of technical methods and pathology 1986;55(1):35-42.
-
1986: Ferrara J; Guillen F J; Sleckman B; Burakoff S J; Murphy G F
Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: histologic analysis and correlation to clinical disease.
The Journal of investigative dermatology 1986;86(4):371-5.
-
1985: Smith B R; Guinan E C; Parkman R; Ferrara J; Levey R H; Nathan D G; Rappeport J M
Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia.
Transplantation 1985;39(6):671-3.
-
1985: Ferrara J; Mauch P; Murphy G; Burakoff S J
Bone marrow transplantation: the genetic and cellular basis of resistance to engraftment and acute graft-versus-host disease.
Survey of immunologic research 1985;4(4):253-63.
Sign-in to see more
